Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome

Condition:   PCOS Interventions:   Drug: Sitagliptin;   Behavioral: Lifestyle intervention Sponsor:   University Medical Centre Ljubljana Completed - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials